Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence
Open Access
- 10 December 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (50)
Abstract
Gene expression profiling of medulloblastoma cells undergoing therapy identifies BPIFB4 as a novel target for recurrent disease.Keywords
This publication has 45 references indexed in Scilit:
- Clonal selection drives genetic divergence of metastatic medulloblastomaNature, 2012
- Clonal evolution in cancerNature, 2012
- Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samplesActa Neuropathologica, 2011
- BMI1 Confers Radioresistance to Normal and Cancerous Neural Stem Cells through Recruitment of the DNA Damage Response MachineryJournal of Neuroscience, 2010
- Myelin mapping in the living mouse brain using manganese-enhanced magnetization transfer MRINeuroImage, 2010
- AMP-activated protein kinase and nitric oxide regulate the glucose sensitivity of ventromedial hypothalamic glucose-inhibited neuronsAmerican Journal of Physiology-Cell Physiology, 2009
- Hepatocyte survival in acute hepatitis is due to c-Jun/AP-1-dependent expression of inducible nitric oxide synthaseProceedings of the National Academy of Sciences, 2007
- Nitric Oxide in Physiologic Concentrations Targets the Translational Machinery to Increase the Proliferation of Human Breast Cancer Cells: Involvement of Mammalian Target of Rapamycin/eIF4E PathwayCancer Research, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Localization of nitric oxide synthase indicating a neural role for nitric oxideNature, 1990